Analyst Price Targets — PFE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 9:45 am | — | HSBC | $28.00 | $24.32 | TheFly | Pfizer downgraded to Hold from Buy at HSBC |
| May 27, 2026 1:46 pm | Michael Yee | UBS | $27.00 | $26.35 | StreetInsider | UBS Reiterates Neutral Rating on Pfizer (PFE) |
| May 14, 2026 11:51 am | Alexandria Hammond | Wolfe Research | $26.00 | $25.96 | TheFly | Pfizer price target raised to $26 from $25 at Wolfe Research |
| March 17, 2026 12:39 pm | Terence Flynn | Morgan Stanley | $27.00 | $27.06 | StreetInsider | Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive' |
| March 9, 2026 3:51 pm | Evan David Seigerman | BMO Capital | $30.00 | $26.49 | StreetInsider | BMO Capital Reiterates Outperform Rating on Pfizer (PFE) following Ph2 data |
| February 24, 2026 9:05 pm | Trung Huynh | RBC Capital | $25.00 | $27.14 | StreetInsider | RBC Capital Starts Pfizer (PFE) at Underperform |
| February 19, 2026 9:17 pm | Emily Field | Barclays | $25.00 | $26.86 | TheFly | Pfizer initiated with an Underweight at Barclays |
| February 12, 2026 10:10 am | Narumi Nakagiri | Daiwa | $27.00 | $27.73 | TheFly | Pfizer downgraded to Neutral from Outperform at Daiwa |
| January 27, 2026 12:21 pm | — | Cantor Fitzgerald | $27.00 | $25.88 | TheFly | Pfizer price target raised to $27 from $24 at Cantor Fitzgerald |
| January 6, 2026 10:06 pm | — | UBS | $25.00 | $25.43 | TheFly | Pfizer assumed with a Neutral at UBS |
Latest News for PFE
All three can be bought on the dip.
PFE trades below key moving averages as investors weigh fading COVID sales against pipeline growth, acquisitions and a low valuation with a high dividend.
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (“LNP”) technology against Pfizer and BioNTech
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Pfizer (NYSE:PFE) both closed Q1 2026 with earnings beats, yet their post-report stories look nothing alike.
Pfizer (NYSE:PFE | PFE Price Prediction) trades at $24.25, against a Wall Street consensus price target of $28.79, which represents implied upside of almost 19%.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.